Daxor Announces the Receipt of a Contract for the Placement

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Daxor Announces the Receipt of a Contract for the Placement of a BVA-100 Blood Volume Analyzer at Lankenau Medical Center

NEW YORK, NY--(Marketwired - Apr 28, 2015) - Daxor Corporation, ( NYSE MKT : DXR ) a medical instrumentation and biotechnology company, announced the receipt of a signed contract from Lankenau Medical Center of Wynnewood, Pennsylvania, for the placement of a BVA-100 Blood Volume Analyzer. Lankenau Medical Center is a 331 bed tertiary care, teaching hospital and research institute 

Lankenau Medical Center serves southeastern Pennsylvania by offering a wide variety of primary and specialty clinical services, residency and fellowship programs, research programs emphasizing cardiovascular disease, cancer and diabetes. Their Emergency Department is certified by the Joint Commission as a Primary Stroke Center. An FAA certified rooftop helipad is available for medevacs.

Lankenau Medical Center is a founding member of Main Line Health, which is a community-based not-for-profit health system that also includes Bryn Mawr Hospital, Paoli Hospital, Riddle Hospital, Bryn Mawr Rehabilitation Hospital, and Mirmont Treatment Center.

Dr. Christopher Droogan, Medical Director of Heart Failure at Lankenau Medical Center, was quoted as saying the following regarding the upcoming placement of the BVA-100 Blood Volume Analyzer:

"In an effort to effectively diagnose proper volume status in many of our critically ill medical and surgical patients as well as the varied heart failure population in our hospital, we look forward to using the Daxor Blood Volume Analyzer to assist our clinicians in their daily practice of medicine. We hope to eliminate unnecessary blood transfusions and decrease invasive hemodynamic monitors which carry risk. In an effort to reduce early readmission we hope to better appreciate the under-treated acutely decompensated heart failure patient."

Dr. Joseph Feldschuh, a cardiologist and the CEO of Daxor, said: "As patients become more aware of how essential blood volume measurement is, they will better understand the importance of being treated on the basis of direct measurement rather than estimates based on imprecise measures."

The Daxor website provides important additional information to help patients understand the benefit of blood volume measurement and which medical facilities in various states across the country are able to provide this life saving test.

To learn more about Daxor, please visit www.Daxor.com .

Contact Information: Daxor Corporation: Richard Dunn 212-330-8502 (Director of Operations) rdunn@daxor.com David Frankel 212-330-8504 (Chief Financial Officer) dfrankel@daxor.com Diane Meegan 212-330-8512 (Investor Relations) dmeegan@daxor.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

AI's Dramatic Impact on Education: Market Set to Expand Significantly

Updated Category News Views 175

AI's Transformative Role in the Education Sector The artificial intelligence (AI) market in the education sector is experiencing a significant upswing. Recent analysis indicates that this market could potentially increase by USD 2.32 billion from 2024 to 2028. The growth rate is projected at an impressive CAGR of approximately 52.65%. What’s fueling this remarkable...

Continue Reading
Badge Inc. Celebrates Five Distinguished Global InfoSec Awards

Updated Category News Views 343

Badge Inc. Celebrates Five Distinguished Global InfoSec Awards Badge Inc., an award-winning privacy company known for enabling Identity without Secrets™, has recently triumphed at the Global InfoSec Awards. This year, the company garnered recognition in five significant categories at the 13th Annual event during the RSA Conference 2025. Recognition for Innovative...

Continue Reading
FAT Brands Inc. Reports Q2 2025 Results and Expansion Plans

Updated Category News Views 249

FAT Brands Inc. Financial Overview for Second Quarter 2025 Join the live conference call today at 4:30 p.m. ET LOS ANGELES — FAT Brands Inc. (NASDAQ: FAT) has released its financial results for the second quarter of 2025, concluding on June 29. As the company remains committed to expanding its market presence, this quarter highlights both achievements and challenges....

Continue Reading
Macrium Software Introduces Innovative Partner Program for Growth

Updated Category News Views 110

Macrium Software Introduces New Partner Program Macrium Software, a well-respected name in the field of backup, recovery, and deployment solutions, is taking a significant step forward by launching its new Macrium Partner Program (MAPP) on a noteworthy day dedicated to data protection. This initiative aims to refine and expand upon Macrium's existing partner framework,...

Continue Reading
Cardinal Midstream Wins $52M Case Against Energy Transfer

Updated Category News Views 340

Major Legal Win for Cardinal Midstream In a significant legal development, a state court awarded over $51 million to Cardinal Midstream II, LLC following a protracted dispute with Energy Transfer, LP. This ruling stems from a contract disagreement regarding an earnout payment that was owed to Cardinal, leading to an important precedent in contract enforcement within the...

Continue Reading